Mef2c regulates bone mass through Sost-dependent and -independent mechanisms

Cesar Morfin; Aimy Sebastian; Stephen P Wilson; Beheshta Amiri; Deepa K Murugesh; Nicholas R Hum; Blaine A Christiansen; Gabriela G Loots

doi:10.1016/j.bone.2023.116976

Mef2c regulates bone mass through Sost-dependent and -independent mechanisms

Bone. 2024 Feb:179:116976. doi: 10.1016/j.bone.2023.116976. Epub 2023 Nov 30.

Authors

Cesar Morfin¹, Aimy Sebastian², Stephen P Wilson², Beheshta Amiri², Deepa K Murugesh², Nicholas R Hum², Blaine A Christiansen³, Gabriela G Loots⁴

Affiliations

¹ School of Natural Sciences, University of California, Merced, CA, United States; Physical and Life Sciences Directorate, Lawrence Livermore, National Laboratories, Livermore, CA, United States; Department of Orthopaedic Surgery, University of California Davis Health, Sacramento, CA, United States.
² Physical and Life Sciences Directorate, Lawrence Livermore, National Laboratories, Livermore, CA, United States.
³ Department of Orthopaedic Surgery, University of California Davis Health, Sacramento, CA, United States.
⁴ School of Natural Sciences, University of California, Merced, CA, United States; Physical and Life Sciences Directorate, Lawrence Livermore, National Laboratories, Livermore, CA, United States; Department of Orthopaedic Surgery, University of California Davis Health, Sacramento, CA, United States. Electronic address: gloots@ucdavis.edu.

PMID: 38042445
DOI: 10.1016/j.bone.2023.116976

Abstract

Mef2c is a transcription factor that mediates key cellular behaviors that promote endochondral ossification and bone formation. Previously, Mef2c has been shown to regulate Sost transcription via its osteocyte-specific enhancer, ECR5, and conditional deletions of Mef2c^fl/fl with either Col1-Cre or Dmp1-Cre produced generalized high bone mass (HBM) consistent with Van Buchem Disease phenotypes. However, Sost^-/-; Mef2c^fl/fl; Dmp1-Cre mice produced a significantly higher bone mass phenotype that Sost^-/- alone suggesting that Mef2c modulates bone mass through additional mechanisms, independent of Sost. To identify new Mef2c transcriptional targets important in bone metabolism, we profiled gene expression by single-cell RNA sequencing in subpopulations of cells isolated from Mef2c^fl/fl; Dmp1-Cre and Mef2c^fl/fl; Bglap-Cre femurs, both strains exhibiting similar high bone mass phenotypes. However, we found Mef2c^fl/fl; Bglap-Cre to also display a growth plate defect characterized by an expansion of several osteoprogenitor subpopulations. Differential gene expression analysis identified a total of 96 up- and 2434 down- regulated genes in Mef2c^fl/fl; Bglap-Cre and 176 up- and 1041 down- regulated genes in Mef2c^fl/fl; Dmp1-Cre bone cell subpopulations compared to wildtype mice. Mef2c deletion affected the transcriptomes across several cell types including mesenchymal progenitors (MP), osteoprogenitors (OSP), osteoblast (OB), and osteocyte (OCY) subpopulations. Several energy metabolism genes such as Uqcrb, Ndufv2, Ndufs3, Ndufa13, Ndufb9, Ndufb5, Cox6a1, Cox5a, Atp5o, Atp5g2, Atp5b, Atp5 were significantly down regulated in Mef2c-deficient OBs and OCYs, in both strains. Binding motif analysis of promoter regions of differentially expressed genes identified Mef2c binding in Bone Sialoprotein (BSP/Ibsp), a gene known to cause increased trabecular BV/TV in the femurs of Ibsp^-/- mice. Immunohistochemical analysis confirmed the absence of Ibsp protein in OBs and OCYs. These findings suggests that the HBM in Sost^-/-; Mef2c^fl/fl; Dmp1-Cre is caused by a multitude of transcriptional changes in genes that regulate bone formation, two of which are Sost and Ibsp.

Keywords: BSP; High bone mass; Ibsp; Mef2; Mef2c; Osteoblast; Osteocyte; Sost; Van Buchem Disease; scRNA-seq; sclerostin.

Publication types

Research Support, U.S. Gov't, Non-P.H.S.
Research Support, N.I.H., Extramural

MeSH terms

Adaptor Proteins, Signal Transducing* / genetics
Adaptor Proteins, Signal Transducing* / metabolism
Animals
Bone and Bones* / metabolism
Electron Transport Complex IV / metabolism
Gene Expression Regulation
MEF2 Transcription Factors* / genetics
Mice
Osteoblasts / metabolism
Osteogenesis / genetics

Substances

Adaptor Proteins, Signal Transducing
Cox6a1 protein, mouse
Electron Transport Complex IV
MEF2 Transcription Factors
Mef2c protein, mouse
Sost protein, mouse

Supplementary concepts

Sclerosteosis

Grants and funding

R56 DK110145/DK/NIDDK NIH HHS/United States